Philogen will be attending the PEGS Europe Virtual Conference from November 9 to 12, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Presentation in the Tumor Microenvironment Session (Immunotherapy Stream) on November 10 with the title: Immunocytokines with "Activity on Demand".
Prof. Dario Neri will also give a Lecture in the Antibody-Drug Conjugates Session (Oncology Stream) on November 10 with the title: Antibody-Drug Conjugates (ADCs) and Small-Molecule Drug Conjugates (SMDCs): A Comparative Analysis.
Philochem will be attending the Festival of Biologics virtual conference from November 2nd to 6th, 2020.
Dr. Samuele Cazzamalli (Group Leader Small-Molecule Therapeutics) and Sheila Dakhel, (Associate Research Scientist) will give a lecture
Philogen will be attending the Next Generation Protein Therapeutics & Bioconjugates Summit from November 2 to 5, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Lecture with the title: Cancer Therapy Using Antibody-Cytokine Fusion Proteins.
Philogen will be attending the World ADC Digital Conference from September 15 to 18, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Plenary Lecture on: “Small Molecule-drug Conjugates (SMDCs) & ADCs: A Comparative Evaluation”.
Philochem announces a publication entitled: “A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients”
Link to Paper
Philochem announces a publication entitled: “On-DNA hit validation methodologies for ligands identified from DNA-encoded chemical libraries”
Link to Paper
Philogen announces option excercise by JanssenPHILOGEN ANNOUNCES OPTION EXERCISE BY JANSSEN .pdf
Philochem is happy to announce the start of an Innosuisse collaboration with the Department of Neurology at the University Hospital and University of Zurich. During the collaboration, both teams will explore the usage of novel Immunocytokines for the treatment of brain tumors in preclinical mouse models facilitating the development of novel brain tumor therapies.
Philochem announces a publication entitled: “Critical Evaluation of Photo-cross-linking Parameters for the Implementation of Efficient DNA-Encoded Chemical Library Selections”
Link to Paper
Philochem will be attending the 10th World ADC Conference in London (United Kingdom) from March 2 to 5, 2020
10th World ADC London
Dr. Samuele Cazzamalli will give a plenary lecture on: “Small Molecule-DrugConjugates: Getting small to enhance targeting”
Jacopo Millul will give a presentation on: “Encoded Self-Assembling Chemical Libraries for the Discovery of New Small Molecules for Tumour-Associated Antigens”